首页 > 最新文献

Journal of Clinical and Aesthetic Dermatology最新文献

英文 中文
Is Acne the Same Around the World? 全世界的痤疮都一样吗?
Q2 Medicine Pub Date : 2024-09-01
Andrew Alexis, Jerry Tan, Marco Rocha, Delphine Kerob, Ann'Laure Demessant, Fatimata Ly, Yan Wu, Mukta Sachdev, Ichiro Kurokawa

Acne is a common skin disease associated with a range of sequelae. These include scarring and dyspigmentation, emotional and psychosocial disturbances, and occupational problems, in part because acne often manifests on the face, in addition to other body areas, and is highly visible. Worldwide, the prevalence of acne is estimated at 9.4 percent; it is most common in adolescents but also affects a relatively high proportion of adults. Early studies of acne epidemiology were conducted primarily in the United States and the United Kingdom. In more recent decades, data have been increasing for other areas of the world. There has also been more attention devoted to how acne may present and be managed in individuals with skin of color (i.e., the broad and diverse range of populations that self-identify as belonging to a non-White racial/ethnic group and share characteristics such as higher skin phototypes and propensity toward hyperpigmentation). This review seeks to highlight aspects of acne that may be unique to skin of color.

痤疮是一种常见的皮肤病,会带来一系列后遗症。这些后遗症包括疤痕和色素沉着、情绪和社会心理障碍以及职业问题,部分原因是痤疮除了出现在身体其他部位外,还常常出现在面部,而且非常明显。在全球范围内,痤疮的发病率估计为 9.4%;痤疮在青少年中最为常见,但在成年人中的发病率也相对较高。早期的痤疮流行病学研究主要在美国和英国进行。近几十年来,世界其他地区的数据也在不断增加。痤疮在有色人种(即自我认同属于非白人种族/族裔群体,并具有较高皮肤光型和色素沉着倾向等共同特征的广泛而多样的人群)中的表现和管理也受到了更多关注。本综述旨在强调有色人种皮肤可能特有的痤疮问题。
{"title":"Is Acne the Same Around the World?","authors":"Andrew Alexis, Jerry Tan, Marco Rocha, Delphine Kerob, Ann'Laure Demessant, Fatimata Ly, Yan Wu, Mukta Sachdev, Ichiro Kurokawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acne is a common skin disease associated with a range of sequelae. These include scarring and dyspigmentation, emotional and psychosocial disturbances, and occupational problems, in part because acne often manifests on the face, in addition to other body areas, and is highly visible. Worldwide, the prevalence of acne is estimated at 9.4 percent; it is most common in adolescents but also affects a relatively high proportion of adults. Early studies of acne epidemiology were conducted primarily in the United States and the United Kingdom. In more recent decades, data have been increasing for other areas of the world. There has also been more attention devoted to how acne may present and be managed in individuals with skin of color (i.e., the broad and diverse range of populations that self-identify as belonging to a non-White racial/ethnic group and share characteristics such as higher skin phototypes and propensity toward hyperpigmentation). This review seeks to highlight aspects of acne that may be unique to skin of color.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"16-22"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Does Pigmented Purpuric Dermatosis Result in Residual Pigmentation in Contrast to Senile Purpura? 与老年性紫癜相比,色素性紫癜皮肤病为何会导致残留色素?
Q2 Medicine Pub Date : 2024-09-01
Yasuhiro Horiuchi
{"title":"Why Does Pigmented Purpuric Dermatosis Result in Residual Pigmentation in Contrast to Senile Purpura?","authors":"Yasuhiro Horiuchi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"14-15"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Update on Prurigo Nodularis in Skin of Color. 有色人种皮肤结节性瘙痒症的最新进展。
Q2 Medicine Pub Date : 2024-09-01
Archana M Sangha
{"title":"An Update on Prurigo Nodularis in Skin of Color.","authors":"Archana M Sangha","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9-10 Suppl 1","pages":"S28-S29"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of GLP-1 Agonists in the Management of Cutaneous Disease. 使用 GLP-1 激动剂治疗皮肤病。
Q2 Medicine Pub Date : 2024-09-01
Karan Lal, Emilee Herringshaw

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications indicated for type 2 diabetes and obesity that may play a role in the management of cutaneous disease, in part due to their anti-inflammatory effects. These molecules interact with cytokines critical to the development and persistence of skin disease, such as TNF-α, IL-23, IL-17 and IL-22. Correspondingly, immunologic pathways that are downregulated by GLP-1 agonists may serve as a target for various skin conditions that are worsened by inflammation. Furthermore, the known benefit of weight loss for certain skin conditions may be further potentiated by GLP-1 agonists. In this brief report, the authors describe multiple cases of patients with psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease for which patients experienced improvement subsequent to treatment with GLP-1 therapy. These cases demonstrate the utility of GLP-1 agonists in treating dermatologic conditions that are refractory to other therapies and further highlight the potential of GLP-1 agonists in treating skin disease.

胰高血糖素样肽-1(GLP-1)激动剂是一类用于治疗 2 型糖尿病和肥胖症的药物,可能在皮肤病的治疗中发挥作用,部分原因是它们具有抗炎作用。这些分子与对皮肤病的发展和持续至关重要的细胞因子(如 TNF-α、IL-23、IL-17 和 IL-22)相互作用。相应地,GLP-1 促效剂下调的免疫途径可作为治疗各种因炎症而恶化的皮肤病的靶点。此外,已知的减肥对某些皮肤病的益处可能会通过 GLP-1 激动剂得到进一步加强。在这篇简短的报告中,作者描述了多例银屑病、化脓性扁桃体炎、黑棘皮症和海利-海利病患者在接受 GLP-1 治疗后病情得到改善的病例。这些病例证明了 GLP-1 激动剂在治疗其他疗法难治的皮肤病方面的作用,并进一步凸显了 GLP-1 激动剂在治疗皮肤病方面的潜力。
{"title":"The Use of GLP-1 Agonists in the Management of Cutaneous Disease.","authors":"Karan Lal, Emilee Herringshaw","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Glucagon-like peptide-1 (GLP-1) agonists are a class of medications indicated for type 2 diabetes and obesity that may play a role in the management of cutaneous disease, in part due to their anti-inflammatory effects. These molecules interact with cytokines critical to the development and persistence of skin disease, such as TNF-α, IL-23, IL-17 and IL-22. Correspondingly, immunologic pathways that are downregulated by GLP-1 agonists may serve as a target for various skin conditions that are worsened by inflammation. Furthermore, the known benefit of weight loss for certain skin conditions may be further potentiated by GLP-1 agonists. In this brief report, the authors describe multiple cases of patients with psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease for which patients experienced improvement subsequent to treatment with GLP-1 therapy. These cases demonstrate the utility of GLP-1 agonists in treating dermatologic conditions that are refractory to other therapies and further highlight the potential of GLP-1 agonists in treating skin disease.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"34-37"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Trichloroacetic Acid Peels in the Treatment of Melasma: A Split-face, Randomized, Prospective Trial in Latin American Women. 三氯乙酸换肤治疗黄褐斑的安全性和有效性:针对拉丁美洲女性的分面、随机、前瞻性试验。
Q2 Medicine Pub Date : 2024-09-01
Deyson Lorenzo-Ríos, Gabriel Arias Berrios, Grecia I Cruz Goytía, Sofía Laguna Rocafort, Cristina N Brau Javier

Background: There is controversy on the efficacy and safety of chemical peels used to treat Hispanic women with melasma. Studies evaluating superficial peels for melasma are limited due to lack of controls, blinding or objective assessment tools, poor inclusion of darker phototypes, and small sample number.

Objectives: We sought to evaluate the safety and efficacy of trichloroacetic acid (TCA) peels when added to hydroquinone and tretinoin in the treatment of melasma in Hispanic women.

Methods: A single blinded, prospective, split-face trial of superficial TCA peels was performed on Hispanic women with melasma. Topical hydroquinone and tretinoin were used on both sides. A total of four monthly peels were performed on one side. The relative reduction of melasma severity was evaluated using narrowband reflectance spectrophotometry (NRS), Modified Melasma Area and Severity Index (mMASI), and Global Melasma Severity Assessment (GMSA). Adverse events were monitored.

Results: Thirty-three patients completed the study. Pigment intensity was reduced on both sides based on all measures. A greater improvement of mMASI and GMSA was achieved on the peeled side.

Limitations: Limitations include the single-center study design with one blinded investigator.

Conclusion: Based on our results, TCA peels appear to be safe and effective in augmenting treatment response on melasma patients with phototypes III and IV treated with hydroquinone and tretinoin.

背景:关于化学换肤治疗西班牙裔女性黄褐斑的有效性和安全性存在争议。由于缺乏对照组、盲法或客观评估工具,较深肤色的患者很少被纳入研究范围,而且样本数量较少,因此评估表层换肤治疗黄褐斑的研究非常有限:我们试图评估三氯乙酸(TCA)换肤与氢醌和曲安奈德一起用于治疗西班牙裔女性黄褐斑的安全性和有效性:方法:对患有黄褐斑的西班牙裔女性进行了单盲、前瞻性、分面浅层三氯乙酸换肤试验。双面均使用外用氢醌和曲安奈德。一侧每月共进行四次换肤。使用窄带反射分光光度法(NRS)、改良黄褐斑面积和严重程度指数(mMASI)以及全球黄褐斑严重程度评估(GMSA)评估黄褐斑严重程度的相对减轻情况。对不良反应进行了监测:33名患者完成了研究。根据所有测量结果,两侧色素强度均有所降低。换肤侧的 mMASI 和 GMSA 改善幅度更大:局限性:单中心研究设计,只有一名研究人员是盲人:根据我们的研究结果,TCA换肤在增强使用氢醌和曲安奈德治疗的III型和IV型黄褐斑患者的治疗反应方面似乎是安全有效的。
{"title":"Safety and Efficacy of Trichloroacetic Acid Peels in the Treatment of Melasma: A Split-face, Randomized, Prospective Trial in Latin American Women.","authors":"Deyson Lorenzo-Ríos, Gabriel Arias Berrios, Grecia I Cruz Goytía, Sofía Laguna Rocafort, Cristina N Brau Javier","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>There is controversy on the efficacy and safety of chemical peels used to treat Hispanic women with melasma. Studies evaluating superficial peels for melasma are limited due to lack of controls, blinding or objective assessment tools, poor inclusion of darker phototypes, and small sample number.</p><p><strong>Objectives: </strong>We sought to evaluate the safety and efficacy of trichloroacetic acid (TCA) peels when added to hydroquinone and tretinoin in the treatment of melasma in Hispanic women.</p><p><strong>Methods: </strong>A single blinded, prospective, split-face trial of superficial TCA peels was performed on Hispanic women with melasma. Topical hydroquinone and tretinoin were used on both sides. A total of four monthly peels were performed on one side. The relative reduction of melasma severity was evaluated using narrowband reflectance spectrophotometry (NRS), Modified Melasma Area and Severity Index (mMASI), and Global Melasma Severity Assessment (GMSA). Adverse events were monitored.</p><p><strong>Results: </strong>Thirty-three patients completed the study. Pigment intensity was reduced on both sides based on all measures. A greater improvement of mMASI and GMSA was achieved on the peeled side.</p><p><strong>Limitations: </strong>Limitations include the single-center study design with one blinded investigator.</p><p><strong>Conclusion: </strong>Based on our results, TCA peels appear to be safe and effective in augmenting treatment response on melasma patients with phototypes III and IV treated with hydroquinone and tretinoin.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"28-32"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Combination of BroadBand Light (BBL® HEROTM) and Nonablative Fractionated 1,927nm (MOXITM) Laser for Addressing Solar Lentigines. 宽波段光(BBL® HEROTM)和非烧蚀性 1,927nm 分段激光(MOXITM)的新组合,用于治疗日光性色斑。
Q2 Medicine Pub Date : 2024-09-01
Erin Hennessey

Solar lentigo is a common condition that can affect people of all ages and ethnicities. The effectiveness of combining laser and light-based modalities for reducing solar lentigines was evaluated. Patients received treatment for facial solar lentigines with an advanced pulsed light device (BBL® HEROTM) followed by nonablative fractionated 1,927nm laser (MOXITM) in a single session. Nonmalignant solar lentigines were evaluated through assessment of photographs and VISIA scans taken before and after treatment. Nine patients aged 29 to 64 years were included in this report. Across all nine patients, there was a significant increase in percentile for brown spots on VISIA scans post-treatment. Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this report demonstrate that combining BBL HERO and MOXI is effective for reducing solar lentigines.

日光性色斑是一种常见病,可影响各个年龄段和种族的人群。本研究评估了激光和光疗相结合减少日光性色斑的效果。患者在接受面部日光性色斑治疗时,先使用先进的脉冲光设备(BBL® HEROTM),然后在单次治疗中使用非烧蚀分段式 1,927nm 激光(MOXITM)。通过评估治疗前后的照片和 VISIA 扫描结果,对非恶性日光性色斑进行了评估。本报告共收录了九名 29 至 64 岁的患者。在所有九名患者中,治疗后 VISIA 扫描的褐斑百分位数显著增加。随访时间长短不一;其中一名患者在治疗后近 20 个月,色素沉着明显减少。本报告的结果表明,将 BBL HERO 和 MOXI 结合使用可有效减少日光性色素沉着。
{"title":"A Novel Combination of BroadBand Light (BBL® HERO<sup>TM</sup>) and Nonablative Fractionated 1,927nm (MOXI<sup>TM</sup>) Laser for Addressing Solar Lentigines.","authors":"Erin Hennessey","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Solar lentigo is a common condition that can affect people of all ages and ethnicities. The effectiveness of combining laser and light-based modalities for reducing solar lentigines was evaluated. Patients received treatment for facial solar lentigines with an advanced pulsed light device (BBL® HERO<sup>TM</sup>) followed by nonablative fractionated 1,927nm laser (MOXI<sup>TM</sup>) in a single session. Nonmalignant solar lentigines were evaluated through assessment of photographs and VISIA scans taken before and after treatment. Nine patients aged 29 to 64 years were included in this report. Across all nine patients, there was a significant increase in percentile for brown spots on VISIA scans post-treatment. Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this report demonstrate that combining BBL HERO and MOXI is effective for reducing solar lentigines.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9-10 Suppl 1","pages":"S36-S39"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concealing Meets Healing in the Treatment of Toenail Onychomycosis: A Review of Concurrent Nail Polish Use with Topical Efinaconazole 10% Solution. 治疗趾甲甲癣时的遮盖与愈合:指甲油与 10%埃芬康唑局部溶液同时使用的回顾。
Q2 Medicine Pub Date : 2024-09-01
Bela Pandit, Boni Elewski, Tracey C Vlahovic

Objective: Patients with onychomycosis may use nail polish to camouflage affected nails, despite potential interactions between nail polish use and topical onychomycosis treatments. Our objective was to review available data on nail polish use concurrent with topical efinaconazole 10% solution for the treatment of onychomycosis.

Methods: We conducted a PubMed search and narrative review of data on effects of nail polish on penetration of efinaconazole and clinical studies of efinaconazole in the treatment of toenail onychomycosis concurrent with nail polish use, including results of an investigator-initiated study of gel nail polish pedicures.

Results: In vitro, penetration of efinaconazole through cadaverous nails coated with traditional nail polish was similar to penetration through uncoated nails. In a 52-week clinical study, efinaconazole treatment was associated with similar improvements in onychomycosis severity and clear toenail growth between participants who used traditional nail polish and those who did not use nail polish. In a second clinical study, participants received efinaconazole treatment concurrent with monthly gel nail polish pedicures. After 6 months, 100% of participants tested negative for fungal infection and all experienced visible improvements in treated toenails. Efinaconazole application was associated with degradation of traditional nail polish texture/appearance. In contrast, efinaconazole did not affect the duration, quality, or texture of gel polish.

Limitations: Only four small studies have assessed nail penetration and efficacy of efinaconazole 10% solution with concurrent nail polish use.

Conclusion: Efinaconazole 10% solution demonstrated efficacy in the treatment of toenail onychomycosis among participants concurrently using toenail polish, with no visible impact on gel-polished nails.

目的:尽管指甲油的使用与甲癣的局部治疗之间可能存在相互作用,但甲癣患者可能会使用指甲油来掩盖受影响的指甲。我们的目的是回顾甲油与局部用 10%依芬康唑溶液治疗甲癣的现有数据:我们在PubMed上搜索并综述了指甲油对依芬康唑渗透性影响的数据,以及依芬康唑治疗同时使用指甲油治疗趾甲甲癣的临床研究,包括一项由研究者发起的凝胶甲油修脚研究的结果:在体外,依芬那唑在涂有传统指甲油的尸体指甲中的渗透率与在未涂指甲油的指甲中的渗透率相似。在一项为期 52 周的临床研究中,使用传统指甲油和不使用指甲油的参与者在甲癣严重程度和趾甲生长清晰度方面的改善情况相似。在第二项临床研究中,参与者在接受依芬康唑治疗的同时,每月涂抹凝胶甲油修脚。6 个月后,100% 的参与者真菌感染检测结果均为阴性,所有接受治疗的人的脚趾甲都有明显改善。应用依芬康唑与传统指甲油质地/外观的退化有关。相比之下,依芬康唑不会影响凝胶甲油的持续时间、质量或质地:局限性:只有四项小型研究评估了同时使用甲油的 10%依芬康唑溶液的指甲渗透性和疗效:结论:10%的依芬康唑溶液对同时使用甲油的参与者治疗趾甲甲癣有疗效,但对涂过凝胶的指甲没有明显影响。
{"title":"Concealing Meets Healing in the Treatment of Toenail Onychomycosis: A Review of Concurrent Nail Polish Use with Topical Efinaconazole 10% Solution.","authors":"Bela Pandit, Boni Elewski, Tracey C Vlahovic","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Patients with onychomycosis may use nail polish to camouflage affected nails, despite potential interactions between nail polish use and topical onychomycosis treatments. Our objective was to review available data on nail polish use concurrent with topical efinaconazole 10% solution for the treatment of onychomycosis.</p><p><strong>Methods: </strong>We conducted a PubMed search and narrative review of data on effects of nail polish on penetration of efinaconazole and clinical studies of efinaconazole in the treatment of toenail onychomycosis concurrent with nail polish use, including results of an investigator-initiated study of gel nail polish pedicures.</p><p><strong>Results: </strong><i>In vitro</i>, penetration of efinaconazole through cadaverous nails coated with traditional nail polish was similar to penetration through uncoated nails. In a 52-week clinical study, efinaconazole treatment was associated with similar improvements in onychomycosis severity and clear toenail growth between participants who used traditional nail polish and those who did not use nail polish. In a second clinical study, participants received efinaconazole treatment concurrent with monthly gel nail polish pedicures. After 6 months, 100% of participants tested negative for fungal infection and all experienced visible improvements in treated toenails. Efinaconazole application was associated with degradation of traditional nail polish texture/appearance. In contrast, efinaconazole did not affect the duration, quality, or texture of gel polish.</p><p><strong>Limitations: </strong>Only four small studies have assessed nail penetration and efficacy of efinaconazole 10% solution with concurrent nail polish use.</p><p><strong>Conclusion: </strong>Efinaconazole 10% solution demonstrated efficacy in the treatment of toenail onychomycosis among participants concurrently using toenail polish, with no visible impact on gel-polished nails.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"38-42"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Accuracy of Skin Cancer Detection Rates with the Implementation of Dermoscopy Among Dermatology Clinicians: A Scoping Review. 皮肤科临床医生使用皮肤镜检查皮肤癌的准确率:范围审查。
Q2 Medicine Pub Date : 2024-09-01
Kathryn Harrison

Objective: The goal is to determine if the implementation of dermoscopy improves the accuracy, specificity, and sensitivity rates of skin cancer detection among dermatology clinicians and identify the optimal training method for dermatology clinicians to become proficient in dermoscopy.

Methods: A comprehensive search through the A.T. Still Memorial Library, including the electronic health databases PubMed, Scopus, UpToDate, and CINAHL, was performed. Google Scholar search results were sorted by relevance, and the first 30 pages were included within the search due to the large quantity of results. The search keywords included "skin cancer diagnosis," "accuracy," "detection," "dermoscopy," and "dermatologists." The search was performed in July 2023. The date limitations used within the search parameters ranged from 2017 to 2023 to review the past seven years of publications. The search evaluated reference lists and encompassed those that met the inclusion and exclusion criteria. Dermatologists, dermatology physician assistants, dermatology nurse practitioners, and primary care practitioners were eligible for inclusion. The search included literature from any country. The English language was the only language permitted within the search. Gray literature was included in the search using news, press release, and MedRxiv.

Results: A total of 28 articles met the inclusion criteria. All of the articles included were from peer-reviewed sources and in the English language. The articles came from 10 different countries of origin and were published from 2017 to 2023. The main results of the scoping review discovered that the use of dermoscopy improves the accuracy of skin cancer diagnosis. The results also demonstrated that dermoscopy training is highly variable; multiple different types of diagnostic algorithms are used in the professional medical education systems of the 10 countries included within the scoping review. The dermoscopy training algorithms recommended include pattern analysis, 7-point checklist, Menzies method, Triage Amalgamated Dermoscopy Algorithm, Australasian College of Dermatology Dermoscopy Course, 3-point checklist, ABCD rule, Skin Imaging College of China, and no particular algorithm. Of these, the three most commonly recommended included the 7-point checklist, Menzies method, and pattern analysis.

Conclusion: The results demonstrated that dermoscopy improves the accuracy of skin cancer diagnosis for dermatology clinicians and primary care providers. Key implications of these findings for practice include earlier skin cancer detection, which can lead to reduced rates of morbidity and mortality, reduced overall healthcare costs, reduced number of benign lesions biopsied, and improved patient outcomes.

目标:目的是确定皮肤镜检查的实施是否能提高皮肤科临床医生皮肤癌检测的准确性、特异性和灵敏度,并确定皮肤科临床医生熟练掌握皮肤镜检查的最佳培训方法:在 A.T. Still 纪念图书馆进行了全面搜索,包括电子健康数据库 PubMed、Scopus、UpToDate 和 CINAHL。谷歌学术搜索结果按相关性排序,由于结果数量庞大,搜索范围包括前 30 页。搜索关键词包括 "皮肤癌诊断"、"准确性"、"检测"、"皮肤镜 "和 "皮肤科医生"。搜索于 2023 年 7 月进行。搜索参数中使用的日期限制从 2017 年到 2023 年不等,以回顾过去七年的出版物。搜索评估了参考文献列表,包括符合纳入和排除标准的文献。皮肤科医生、皮肤科医生助理、皮肤科护士和初级保健医生均符合纳入条件。检索包括来自任何国家的文献。英语是检索中唯一允许使用的语言。灰色文献包括新闻、新闻稿和MedRxiv.Results:共有 28 篇文章符合纳入标准。所有纳入的文章均来自同行评议来源,并使用英语。这些文章来自 10 个不同的国家,发表于 2017 年至 2023 年。范围界定审查的主要结果发现,使用皮肤镜可提高皮肤癌诊断的准确性。结果还表明,皮肤镜检查培训存在很大差异;在范围界定综述所包括的 10 个国家的专业医学教育系统中,使用了多种不同类型的诊断算法。推荐的皮肤镜检查培训算法包括模式分析、7 点检查表、孟席斯方法、Triage Amalgamated Dermoscopy Algorithm、澳大利亚皮肤病学院皮肤镜检查课程、3 点检查表、ABCD 规则、中国皮肤影像学院以及无特定算法。其中,最常推荐的三种算法包括 7 点检查表、孟席斯法和模式分析:结论:研究结果表明,皮肤镜提高了皮肤科临床医生和初级保健提供者诊断皮肤癌的准确性。这些研究结果对临床实践的主要影响包括:更早发现皮肤癌,从而降低发病率和死亡率;降低总体医疗成本;减少良性病变活检的数量;改善患者预后。
{"title":"The Accuracy of Skin Cancer Detection Rates with the Implementation of Dermoscopy Among Dermatology Clinicians: A Scoping Review.","authors":"Kathryn Harrison","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The goal is to determine if the implementation of dermoscopy improves the accuracy, specificity, and sensitivity rates of skin cancer detection among dermatology clinicians and identify the optimal training method for dermatology clinicians to become proficient in dermoscopy.</p><p><strong>Methods: </strong>A comprehensive search through the A.T. Still Memorial Library, including the electronic health databases PubMed, Scopus, UpToDate, and CINAHL, was performed. Google Scholar search results were sorted by relevance, and the first 30 pages were included within the search due to the large quantity of results. The search keywords included \"skin cancer diagnosis,\" \"accuracy,\" \"detection,\" \"dermoscopy,\" and \"dermatologists.\" The search was performed in July 2023. The date limitations used within the search parameters ranged from 2017 to 2023 to review the past seven years of publications. The search evaluated reference lists and encompassed those that met the inclusion and exclusion criteria. Dermatologists, dermatology physician assistants, dermatology nurse practitioners, and primary care practitioners were eligible for inclusion. The search included literature from any country. The English language was the only language permitted within the search. Gray literature was included in the search using news, press release, and MedRxiv.</p><p><strong>Results: </strong>A total of 28 articles met the inclusion criteria. All of the articles included were from peer-reviewed sources and in the English language. The articles came from 10 different countries of origin and were published from 2017 to 2023. The main results of the scoping review discovered that the use of dermoscopy improves the accuracy of skin cancer diagnosis. The results also demonstrated that dermoscopy training is highly variable; multiple different types of diagnostic algorithms are used in the professional medical education systems of the 10 countries included within the scoping review. The dermoscopy training algorithms recommended include pattern analysis, 7-point checklist, Menzies method, Triage Amalgamated Dermoscopy Algorithm, Australasian College of Dermatology Dermoscopy Course, 3-point checklist, ABCD rule, Skin Imaging College of China, and no particular algorithm. Of these, the three most commonly recommended included the 7-point checklist, Menzies method, and pattern analysis.</p><p><strong>Conclusion: </strong>The results demonstrated that dermoscopy improves the accuracy of skin cancer diagnosis for dermatology clinicians and primary care providers. Key implications of these findings for practice include earlier skin cancer detection, which can lead to reduced rates of morbidity and mortality, reduced overall healthcare costs, reduced number of benign lesions biopsied, and improved patient outcomes.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9-10 Suppl 1","pages":"S18-S27"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Poster Abstracts From Symposium for Cosmetic Advances & Laser Education (SCALE) 2024. 2024 年美容进展与激光教育研讨会(SCALE)海报摘要选编。
Q2 Medicine Pub Date : 2024-09-01
{"title":"Selected Poster Abstracts From Symposium for Cosmetic Advances & Laser Education (SCALE) 2024.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9 Suppl 2","pages":"S11-S27"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Gender Disparity: A Closer Look at Speaker Representation at International Aesthetic Medicine Conferences. 揭开性别差异的面纱:近距离观察国际美容医学会议上的发言人代表。
Q2 Medicine Pub Date : 2024-09-01
Emmaline Ashley, Priyanka Chadha, Lara Watson

Introduction: Despite some recent progress, gender disparity is a well-documented and persistent problem at medical professional conferences, with women being consistently underrepresented.1 This study examines the representation of speakers at international aesthetic medicine conferences, an area previously unexplored in the literature.

Methodology: An analysis of speaker composition was conducted of three international aesthetic medicine conferences over the past three years: the Aesthetics & Anti-Aging Medicine World Congress (AMWC), the International Master Course on Aging Science (IMCAS) World Congress, and the Facial Aesthetic Conference and Exhibition (FACE).

Results: Of the 5,993 clinical lectures amongst 189 sessions over three years, 66.34 percent were given by male speakers and 33.66 percent by female speakers. The gender disparity remained consistent over the three-year period reviewed, with no upward trend. Symposiums with all-male panels consisted of 26.4 percent of the total sessions.

Conclusion: The study highlights an ongoing gender imbalance at international aesthetic medicine conferences. These disparities have broad and significant implications in terms of inequalities in employment and earnings as well as the perpetuated societal inequalities faced by women. The aesthetic medicine community should therefore consider it a priority to acknowledge and address this issue by supporting improved representation of women at key events and congresses amongst other initiatives to drive positive change.

导言:尽管最近取得了一些进展,但性别差异是医学专业会议中一个有据可查的顽疾,女性代表一直不足1。本研究探讨了国际美容医学会议演讲者的代表情况,这是文献中以前从未探讨过的领域:方法:对过去三年中的三个国际美容医学会议进行了演讲者构成分析:世界美容与抗衰老医学大会(AMWC)、国际衰老科学大师课程(IMCAS)世界大会以及面部美容会议与展览(FACE):结果:在三年中的 189 场会议的 5993 个临床讲座中,66.34% 由男性演讲者主讲,33.66% 由女性演讲者主讲。在审查的三年期间,性别差异保持一致,没有上升趋势。全部由男性组成的专题讨论会占全部会议的 26.4%:这项研究强调了国际美容医学会议中持续存在的性别不平衡现象。这些差异对就业和收入的不平等以及女性长期面临的社会不平等具有广泛而重要的影响。因此,美容医学界应优先考虑承认并解决这一问题,支持提高妇女在重要活动和大会中的代表性,并采取其他措施推动积极变革。
{"title":"Unveiling Gender Disparity: A Closer Look at Speaker Representation at International Aesthetic Medicine Conferences.","authors":"Emmaline Ashley, Priyanka Chadha, Lara Watson","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Despite some recent progress, gender disparity is a well-documented and persistent problem at medical professional conferences, with women being consistently underrepresented.1 This study examines the representation of speakers at international aesthetic medicine conferences, an area previously unexplored in the literature.</p><p><strong>Methodology: </strong>An analysis of speaker composition was conducted of three international aesthetic medicine conferences over the past three years: the Aesthetics & Anti-Aging Medicine World Congress (AMWC), the International Master Course on Aging Science (IMCAS) World Congress, and the Facial Aesthetic Conference and Exhibition (FACE).</p><p><strong>Results: </strong>Of the 5,993 clinical lectures amongst 189 sessions over three years, 66.34 percent were given by male speakers and 33.66 percent by female speakers. The gender disparity remained consistent over the three-year period reviewed, with no upward trend. Symposiums with all-male panels consisted of 26.4 percent of the total sessions.</p><p><strong>Conclusion: </strong>The study highlights an ongoing gender imbalance at international aesthetic medicine conferences. These disparities have broad and significant implications in terms of inequalities in employment and earnings as well as the perpetuated societal inequalities faced by women. The aesthetic medicine community should therefore consider it a priority to acknowledge and address this issue by supporting improved representation of women at key events and congresses amongst other initiatives to drive positive change.</p>","PeriodicalId":53616,"journal":{"name":"Journal of Clinical and Aesthetic Dermatology","volume":"17 9","pages":"25-27"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11386967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical and Aesthetic Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1